In acute metabolic acidosis, rapid changes in extracellular and intracellular pH can lead to significant clinical consequences, particularly in the cardiovascular and respiratory systems. The immediate goal in managing acute metabolic acidosis is to reverse the underlying cause while considering the administration of base therapy, primarily in the form of sodium bicarbonate.
Sodium Bicarbonate Therapy
Sodium bicarbonate has traditionally been the first-line treatment for acute metabolic acidosis. It works by buffering excess hydrogen ions (H+) and raising blood pH. However, the use of sodium bicarbonate is controversial, especially in cases of lactic acidosis or diabetic ketoacidosis (DKA). Clinical trials have not consistently shown that bicarbonate administration reduces morbidity or mortality in these conditions. In addition, bicarbonate therapy can cause adverse effects such as paradoxical intracellular acidosis due to the generation of carbon dioxide (CO2), volume overload, and hypernatremia.
In lactic acidosis, for example, studies have shown that sodium bicarbonate does not improve cardiovascular outcomes or reduce mortality. In children with DKA, bicarbonate administration has been associated with an increased risk of cerebral edema, so it is recommended only when the blood pH is critically low (less than 7.1) and when there is evidence of hemodynamic instability that is not responding to fluids and insulin therapy.
Alternative Buffers
Given the limitations of sodium bicarbonate therapy, other buffers have been explored. Tris-hydroxymethyl aminomethane (THAM) is a buffer that raises extracellular pH without producing CO2, making it an attractive option for patients with CO2 retention. Although THAM has shown promise in raising pH and improving cardiovascular function in animal studies, its use is limited due to potential side effects such as hyperkalemia, liver toxicity, and pulmonary dysfunction. Other experimental buffers, like Carbicarb® and pyruvate, have shown promise in animal studies but are not yet widely used in clinical practice.
Ventilatory Support
In patients with acute metabolic acidosis, ventilatory support may be necessary to compensate for the reduced blood pH. Increasing alveolar ventilation helps reduce PaCO2, raising the blood pH. This is particularly beneficial in patients with CO2 retention or severe acidosis. However, mechanical ventilation must be carefully monitored to avoid complications such as barotrauma.
Hemodialysis
In patients with severe metabolic acidosis due to renal failure or toxic ingestions (e.g., methanol or ethylene glycol), hemodialysis can rapidly correct the acid-base disturbance. Dialysis removes excess acids and corrects electrolyte imbalances, while also allowing for the controlled administration of bicarbonate without causing volume overload or hyperosmolality.
